Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on ruthenium catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Ruthenium-catalyzed preparation method offers high yield and industrial scalability for pharmaceutical intermediates supply chain optimization and significant cost reduction benefits.
Novel Ru-catalyzed C-H activation method for benzindole derivatives offers mild conditions and green solvents, ensuring reliable supply chain and cost efficiency.
Discover how novel biphenyl-type tridentate ligand ruthenium complexes enable ester-to-alcohol hydrogenation at 60-100°C and 3-10MPa, reducing costs and safety risks for pharma production.
Discover scalable ruthenium-catalyzed N-acylpyrrole synthesis with 80% yield. Reduce costs and supply chain risks for pharma R&D and procurement with simplified industrial processes.
Discover a 95%+ yield, explosion-free synthesis of 2-trifluoromethyl dihydrobenzochromene. Eliminate heavy metal risks and scale to 100MT/yr with our CDMO expertise.
Eliminate expensive Pd/Rh catalysts and achieve 87% yield with ruthenium-catalyzed benzidine synthesis - ideal for scalable fungicide production.
Solve high-cost synthesis challenges with room-temperature, water-based production of polysubstituted distyryl indole derivatives. 99% yields, no toxic solvents, and simplified purification.
Discover how ruthenium-catalyzed cyclization eliminates heavy metal waste and reduces production costs for polyaromatic naphthalene derivatives in drug development and optoelectronics.
Solve high-temperature decarboxylation challenges with room-temperature gamma-cyanoolefin synthesis. Achieve 84% yield, 100% purity, and reduced energy costs for pharmaceutical intermediates.
83% yield, catalyst recyclability, and water-only byproduct in quinoline synthesis. Reduce solvent costs and EHS risks for pharma intermediates. Contact for CDMO solutions.